KMT2C promoter methylation in plasma‐circulating tumor DNA is a prognostic biomarker in non‐small cell lung cancer
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
KMT2C
promoter methylation in plasma‐circulating tumor DNA is a prognostic biomarker in non‐small cell lung cancer
Authors
Keywords
-
Journal
Molecular Oncology
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-11-08
DOI
10.1002/1878-0261.12848
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- DNA Methylation-Based Testing in Liquid Biopsies as Detection and Prognostic Biomarkers for the Four Major Cancer Types
- (2020) Vera Constâncio et al. Cells
- KMT2D Deficiency Impairs Super-Enhancers to Confer a Glycolytic Vulnerability in Lung Cancer
- (2020) Hunain Alam et al. CANCER CELL
- The lysine‐specific methyltransferase KMT2C/MLL3 regulates DNA repair components in cancer
- (2019) Theodoros Rampias et al. EMBO REPORTS
- Integrative Genomic Characterization Identifies Molecular Subtypes of Lung Carcinoids
- (2019) Saurabh V. Laddha et al. CANCER RESEARCH
- Epigenetic synthetic lethality approaches in cancer therapy
- (2019) Haoshen Yang et al. Clinical Epigenetics
- Tissue and Cell-Free DNA-Based Epigenomic Approaches for Cancer Detection
- (2019) Alessandro Leal et al. CLINICAL CHEMISTRY
- A Diagnostic Panel of DNA Methylation Biomarkers for Lung Adenocarcinoma
- (2019) Nan Shen et al. Frontiers in Oncology
- Cancer statistics, 2018
- (2018) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Evaluation of Preanalytical Conditions and Implementation of Quality Control Steps for Reliable Gene Expression and DNA Methylation Analyses in Liquid Biopsies
- (2018) Martha Zavridou et al. CLINICAL CHEMISTRY
- Current landscape and future of dual anti-CTLA4 and PD-1/PD-L1 blockade immunotherapy in cancer; lessons learned from clinical trials with melanoma and non-small cell lung cancer (NSCLC)
- (2018) Young Kwang Chae et al. Journal for ImmunoTherapy of Cancer
- MLL3 enhances the transcription of PD-L1 and regulates anti-tumor immunity
- (2018) Wei Xiong et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Mll3 and Mll4 Facilitate Enhancer RNA Synthesis and Transcription from Promoters Independently of H3K4 Monomethylation
- (2017) Kristel M. Dorighi et al. MOLECULAR CELL
- Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution
- (2017) Christopher Abbosh et al. NATURE
- MLL3/MLL4 are required for CBP/p300 binding on enhancers and super-enhancer formation in brown adipogenesis
- (2017) Binbin Lai et al. NUCLEIC ACIDS RESEARCH
- Direct comparison study of DNA methylation markers in EpCAM-positive circulating tumour cells, corresponding circulating tumour DNA, and paired primary tumours in breast cancer
- (2017) Maria Chimonidou et al. Oncotarget
- Reduced Expression of Histone Methyltransferases KMT2C and KMT2D Correlates with Improved Outcome in Pancreatic Ductal Adenocarcinoma
- (2016) J. B. N. Dawkins et al. CANCER RESEARCH
- SOX17 promoter methylation in plasma circulating tumor DNA of patients with non-small cell lung cancer
- (2016) Ioanna Balgkouranidou et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Gene expression profiling and DNA methylation analyses of CTCs
- (2016) Evi S. Lianidou Molecular Oncology
- Multiplatform-based molecular subtypes of non-small-cell lung cancer
- (2016) F Chen et al. ONCOGENE
- Enhancer priming by H3K4 methyltransferase MLL4 controls cell fate transition
- (2016) Chaochen Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as Liquid Biopsy
- (2016) C. Alix-Panabieres et al. Cancer Discovery
- Interaction betweenMLL3genetic polymorphisms, smoking, and alcohol drinking in laryngeal cancer: a case-control study
- (2016) Dong Chen et al. Cancer Medicine
- Detection and Dynamic Changes of EGFR Mutations from Circulating Tumor DNA as a Predictor of Survival Outcomes in NSCLC Patients Treated with First-line Intercalated Erlotinib and Chemotherapy
- (2015) T. Mok et al. CLINICAL CANCER RESEARCH
- Breast cancer metastasis suppressor-1 promoter methylation in cell-free DNA provides prognostic information in non-small cell lung cancer
- (2014) I Balgkouranidou et al. BRITISH JOURNAL OF CANCER
- MLL3 Is a Haploinsufficient 7q Tumor Suppressor in Acute Myeloid Leukemia
- (2014) Chong Chen et al. CANCER CELL
- Exploring the potential of immuno-oncology-based treatment for patients with non-small cell lung cancer
- (2014) David Heigener et al. Expert Review of Anticancer Therapy
- Association of MLL3 expression with prognosis in gastric cancer
- (2014) B. Li et al. GENETICS AND MOLECULAR RESEARCH
- Tumorigenicity and genetic profiling of circulating tumor cells in small-cell lung cancer
- (2014) Cassandra L Hodgkinson et al. NATURE MEDICINE
- Lung cancer epigenetics: emerging biomarkers
- (2013) Ioanna Balgkouranidou et al. Biomarkers in Medicine
- The MLL3/MLL4 Branches of the COMPASS Family Function as Major Histone H3K4 Monomethylases at Enhancers
- (2013) D. Hu et al. MOLECULAR AND CELLULAR BIOLOGY
- H3K4 mono- and di-methyltransferase MLL4 is required for enhancer activation during cell differentiation
- (2013) Ji-Eun Lee et al. eLife
- SOX17 Promoter Methylation in Circulating Tumor Cells and Matched Cell-Free DNA Isolated from Plasma of Patients with Breast Cancer
- (2012) M. Chimonidou et al. CLINICAL CHEMISTRY
- DNA Methylation of Tumor Suppressor and Metastasis Suppressor Genes in Circulating Tumor Cells
- (2011) M. Chimonidou et al. CLINICAL CHEMISTRY
- Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder
- (2011) Yaoting Gui et al. NATURE GENETICS
- PIK3CA Hotspot Mutation Scanning by a Novel and Highly Sensitive High-Resolution Small Amplicon Melting Analysis Method
- (2010) Panagiotis A. Vorkas et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- From discovery to the clinic: the novel DNA methylation biomarkermSEPT9 for the detection of colorectal cancer in blood
- (2010) Shannon R Payne Epigenomics
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started